Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness.
1
Zitationen
14
Autoren
2023
Jahr
Abstract
Overall, the group found a scarcity of systematic data directly assessing the impact of technological innovations on study recruitment and retention in CNS trials, even for strategies with already high adoption, such as online recruitment. Given the added complexity and costs associated with most technological innovations, such data is needed to fully harness technologies for CNS trials and drive further adoption.
Ähnliche Arbeiten
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
2003 · 10.818 Zit.
Estimating the mean and variance from the median, range, and the size of a sample
2005 · 8.922 Zit.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 · 6.932 Zit.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
2020 · 5.203 Zit.
The global landscape of AI ethics guidelines
2019 · 4.482 Zit.
Autoren
Institutionen
- Addgene(US)
- Mental Health Research UK(GB)
- Washington University in St. Louis(US)
- Atrium Medical Cente(US)
- Brigham and Women's Hospital(US)
- IQVIA (United States)(US)
- Boehringer Ingelheim (Brazil)(BR)
- Boehringer Ingelheim (United States)(US)
- nLIGHT (United States)(US)
- Verasci (United States)(US)
- Jnana Therapeutics (United States)(US)
- Lundbeck (Denmark)(DK)
- Usona Institute(US)
- Virginia Tech(US)
- Duke University(US)
- Duke Medical Center(US)